NASDAQ · WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES · LARGE CAP
Henry Schein, Inc. HSIC
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$13.2B
▲ 4.0% vs FY2024
EPS · FY25
$3.27
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
12.0%
Net margin · FY25
3.0%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 13.2B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
3 cents of every revenue dollar became profit this year.
Per share
USD 3.27
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
12.0%
Return on equity, FY2025
ROE
Operating margin5.0%
Net margin3.0%
Return on assets3.7%
Each USD of equity produced 12 cents of profit this year.
Returned to shareholders
USD 600.0M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 600.0M
Share of profit150.8%
Consecutive raises—
USD 600.0M in buybacks — 151% of the year's profit, so the payout drew on cash built up earlier.
Growth
+5.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+1.4%
+5.4%
+2.2%
+3.8%
Net income
−9.6%
−0.3%
−1.8%
+1.3%
EPS, diluted
−5.8%
+3.0%
Returned to shareholders
+7.5%
+52.0%
+7.7%
+25.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.12B
Shares outstanding, FY2025
Change, 5 years−18.7%
Change, 10 years—
The share count shrank 19% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 11.2B
total assets, end of FY2025
Total assetsUSD 11.2B
EquityUSD 3.2B
CashUSD 156.0M
Gross debtUSD 3.1B
Net debtUSD 2.9B
Current ratio1.38×
Net debt stands at 90% of equity.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
13.2
12.7
12.3
12.6
12.4
10.1
10.0
9.4
8.9
11.6
10.6
10.4
9.6
8.9
8.5
7.5
6.5
6.4
Operating income $B
0.7
0.6
0.6
0.7
0.9
0.5
0.7
0.6
0.7
0.8
0.7
0.7
0.7
0.6
0.6
0.5
0.5
0.4
EBITDA $B
1.0
0.9
0.9
1.0
1.1
0.7
0.9
0.7
0.8
0.9
0.9
0.9
0.8
0.7
0.7
0.6
0.5
0.5
Income tax $B
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.1
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
Net income $B
0.4
0.4
0.4
0.5
0.6
0.4
0.7
0.5
0.4
0.5
0.5
0.5
0.4
0.4
0.4
0.3
0.3
0.2
EPS, diluted $
3.27
3.05
3.16
3.91
4.45
2.82
4.65
3.49
2.57
3.10
2.85
5.44
4.93
4.32
3.97
3.49
3.44
2.63
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
12.0
11.1
11.7
15.7
18.6
12.7
23.3
18.6
14.5
17.9
16.8
16.6
16.0
15.4
15.2
14.2
14.4
·
Shares out B
0.12
0.12
0.13
0.13
0.14
0.14
0.14
0.15
0.15
0.16
0.08
0.08
0.09
0.09
0.09
0.09
0.09
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
70 of 70
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed